ARIH2
E3 ubiquitin-protein ligase ARIH2
Also known as: ARI2_HUMAN, TRIAD1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95376
- Gene
- ARIH2
- Ensembl
- ENSG00000177479
- Chromosome
- 3
- Canonical length
- 493 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is an E3 ubiquitin-protein ligase that polyubiquitinates some proteins, tagging them for degradation. The encoded protein upregulates p53 in some cancer cells and may inhibit myelopoiesis. Several transcript variants encoding different isoforms have been found for this gene, although the full-length nature of some of them have not been determined yet. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
493 residues, UniProt reviewed canonical sequence.
>O95376|ARIH2
1 MSVDMNSQGS DSNEEDYDPN CEEEEEEEED DPGDIEDYYV GVASDVEQQG ADAFDPEEYQ
61 FTCLTYKESE GALNEHMTSL ASVLKVSHSV AKLILVNFHW QVSEILDRYK SNSAQLLVEA
121 RVQPNPSKHV PTSHPPHHCA VCMQFVRKEN LLSLACQHQF CRSCWEQHCS VLVKDGVGVG
181 VSCMAQDCPL RTPEDFVFPL LPNEELREKY RRYLFRDYVE SHYQLQLCPG ADCPMVIRVQ
241 EPRARRVQCN RCNEVFCFKC RQMYHAPTDC ATIRKWLTKC ADDSETANYI SAHTKDCPKC
301 NICIEKNGGC NHMQCSKCKH DFCWMCLGDW KTHGSEYYEC SRYKENPDIV NQSQQAQARE
361 ALKKYLFYFE RWENHNKSLQ LEAQTYQRIH EKIQERVMNN LGTWIDWQYL QNAAKLLAKC
421 RYTLQYTYPY AYYMESGPRK KLFEYQQAQL EAEIENLSWK VERADSYDRG DLENQMHIAE
481 QRRRTLLKDF HDTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARIH2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 94 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 94 nTPM
- tongue: 74 nTPM
- heart muscle: 51 nTPM
- choroid plexus: 32 nTPM
- epididymis: 32 nTPM
- retina: 30 nTPM
Single-cell type
- myonuclei: 299 nCPM
- early primary spermatocytes: 251 nCPM
- cardiomyocytes: 222 nCPM
- oligodendrocytes: 150 nCPM
- rod photoreceptor cells: 148 nCPM
- adrenal cortex cells: 146 nCPM
Immune cell
- basophil: 53 nTPM
- gdT-cell: 44 nTPM
- eosinophil: 40 nTPM
- total PBMC: 39 nTPM
- naive CD8 T-cell: 38 nTPM
- memory CD8 T-cell: 37 nTPM
Brain region
- white matter: 33 nTPM
- choroid plexus: 28 nTPM
- basal ganglia: 27 nTPM
- cerebellum: 27 nTPM
- pons: 26 nTPM
- cerebral cortex: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARIH2.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 62 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 3.58
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- developmental cell growth
- hematopoietic stem cell proliferation
- positive regulation of protein targeting to mitochondrion
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein K48-linked ubiquitination
- protein K63-linked ubiquitination
- protein polyubiquitination
- protein ubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
- ubiquitin conjugating enzyme binding
- ubiquitin protein ligase activity
- ubiquitin-protein transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, RING-type
- IBR domain
- Zinc finger, RING/FYVE/PHD-type
- Zinc finger, RING-type, conserved site
- Zinc finger, C3HC4 RING-type
- E3 ubiquitin ligase RBR family
- TRIAD supradomain
- Ariadne domain
- Zinc finger, C3HC4 type (RING finger)
- IBR domain, a half RING-finger domain
- Ariadne domain
- IBR domain
- E3 ubiquitin-protein ligase ARIH2, BRcat domain
- E3 ubiquitin-protein ligase TRIAD1, Rcat domain
- E3 ubiquitin-protein ligase ARIH2, N-terminal UBA domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARIH2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARIH2 as an antibody target. Whether an autoantibody or antibody against ARIH2 could matter depends on whether native ARIH2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARIH2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARIH2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...